Literature DB >> 14707233

Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.

Carlos A Molina1, Joan Montaner, Juan F Arenillas, Marc Ribo, Marta Rubiera, José Alvarez-Sabín.   

Abstract

BACKGROUND AND
PURPOSE: We aimed to evaluate the timing, speed, and degree of tissue plasminogen activator (tPA)-induced recanalization in patients with proximal middle cerebral artery (MCA) occlusion of different stroke subtypes.
METHODS: We evaluated 72 patients with acute stroke caused by proximal MCA occlusion treated with intravenous tPA in <3 hours. Transcranial Doppler monitoring of recanalization was conducted during tPA infusion and at 6 hours. Strokes were categorized as large-vessel disease strokes, cardioembolic strokes, or strokes of undetermined origin according to Trial of Org 10172 in Acute Stroke Treatment criteria.
RESULTS: During 1-hour tPA infusion, recanalization occurred in 34 patients (47%); 32% showed a sudden, 50% showed a stepwise, and 18% showed a slow pattern of recanalization. One-hour recanalization was more frequent in patients with cardioembolic stroke (59%) compared with large-vessel disease (8%) and undetermined origin (50%) strokes. A cardiac source of emboli was identified in 81% of patients who showed a sudden clot breakup during tPA infusion. Rate of complete recanalization at 6 hours was higher (P=0.006) in patients with cardioembolic stroke (50%) compared with other stroke subtypes (27%). Sudden recanalization was associated (P=0.002) with a higher degree of neurological improvement at 24 hours compared with stepwise, slow, and no recanalization. A graded response in long-term outcome was observed in relation to the speed of clot lysis during tPA administration.
CONCLUSIONS: We demonstrate that the pattern of tPA-induced MCA recanalization differs among stroke subtypes. Early recanalization was more frequent, faster, and more complete in patients with cardioembolic stroke compared with other stroke subtypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707233     DOI: 10.1161/01.STR.0000110219.67054.BF

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

Review 1.  The neurovascular unit and combination treatment strategies for stroke.

Authors:  Li Zhang; Zheng Gang Zhang; Michael Chopp
Journal:  Trends Pharmacol Sci       Date:  2012-05-16       Impact factor: 14.819

2.  Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion.

Authors:  Jamie Nicole LaBuzetta; Albert J Yoo; Syed Ali; Kaitlin Fitzpatrick; Thabele Leslie-Mazwi; Joshua A Hirsch; Lee Schwamm; Natalia Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-09-18       Impact factor: 2.136

3.  Thrombolytic therapy for acute ischaemic stroke: what can we do to improve outcomes?

Authors:  Andrew M Demchuk; Simerpreet Bal
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

4.  Relationship between thrombus attenuation and different stroke subtypes.

Authors:  J M Niesten; I C van der Schaaf; G J Biessels; A E van Otterloo; T van Seeters; A D Horsch; M J A Luitse; Y van der Graaf; L J Kappelle; W P T M Mali; B K Velthuis
Journal:  Neuroradiology       Date:  2013-06-21       Impact factor: 2.804

5.  Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator.

Authors:  J Puig; S Pedraza; A Demchuk; J Daunis-I-Estadella; H Termes; G Blasco; G Soria; I Boada; S Remollo; J Baños; J Serena; M Castellanos
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

6.  Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period.

Authors:  G Gascou; K Lobotesis; P Machi; I Maldonado; J F Vendrell; C Riquelme; O Eker; G Mercier; I Mourand; C Arquizan; A Bonafé; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-24       Impact factor: 3.825

7.  Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.

Authors:  Jonathan T Sutton; Nikolas M Ivancevich; Stephen R Perrin; Deborah C Vela; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2013-03-01       Impact factor: 2.998

Review 8.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

9.  Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.

Authors:  Stefano Forlivesi; Paolo Bovi; Giampaolo Tomelleri; Nicola Micheletti; Monica Carletti; Giuseppe Moretto; Manuel Cappellari
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

10.  Novel Thrombolytics for Acute Ischemic Stroke: Challenges and Opportunities.

Authors:  Nicola Logallo; Christopher E Kvistad; Aliona Nacu; Lars Thomassen
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.